CDA Technology is a
Game Changer.
ANPAC BIO'S CDA (CANCER DIFFERENTIATION ANALYSIS) IS A REVOLUTIONARY TECHNOLOGY
LEARN MORE
Results Speak.
20+

CANCER TYPES

75%
TO
90%

ACCURACY RATE

~40K

CONFIRMED TESTS

A Respected Team
Dr. Chris Yu
CO-FOUNDER/ CHIEF EXECUTIVE OFFICER
Dr. Chris Yu attended medical school before changing his studies to Physics and earning his Ph.D. from Pennsylvania State University. He is a successful Fortune 500 business executive, innovative engineer, and pioneering inventor.
FULL BIO
Dr. Herbert Yu
CO-FOUNDER/ CHIEF SCIENCE OFFICER
Dr. Herbert Yu is an M.D, with a Ph.D. in Clinical Biochemistry from University of Toronto. He is a highly acclaimed research director and professor in epidemiology and cancer research at Yale University and University Hawaii.
FULL BIO
Drisha Leggitt
VICE PRESIDENT, BUSINESS DEVELOPMENT
Ms. Leggitt is an internationally recognized marketing and PR professional who has helped lead Fortune 500 technology companies. As a Stage 4 cancer survivor herself, she is passionate about early cancer detection.
FULL BIO
Meet the People Who Are Changing the Game